EMvision Medical Devices Ltd (ASX: EMV) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
EMvision Medical Devices Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
EMvision Medical Devices Ltd (ASX: EMV)
Latest News
Healthcare Shares
This healthcare stock just jumped 15% and experts are tipping a further 80% rise
Small Cap Shares
What is Bell Potter's view on this ASX small-cap following a clinical trial update?
Small Cap Shares
2 ASX shares that could rise 100% according to Bell Potter
Small Cap Shares
Two small caps that could double this year
Healthcare Shares
Why this speculative ASX stock could rise 80%
Small Cap Shares
Why this small cap ASX share could rise 60%+
ASX Share Market News
Why did this ASX health care stock just plummet 12%?
Healthcare Shares
This ASX healthcare stock could be a buy low bargain
Earnings Results
3 ASX shares soaring on earnings updates
Healthcare Shares
EMvision share price rockets 11% on $5 million pay day
Technology Shares
Here's why the EMvision share price surged 8% on Wednesday
Healthcare Shares
EMvision (ASX:EMV) share price slides 5% following FDA update
EMV ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About EMvision Medical Devices Ltd
EMvision Medical Devices Ltd. engages in the development & commercialization of medical imaging technology. It is developing portable electromagnetic tomography solutions. EMvision Medical Devices was founded on July 11, 2017 and is headquartered in Brisbane, Australia.
EMV Share Price History Data provided by Morningstar.
| Date | Close | Change | % Change | Volume | Open | High | Low |
|---|---|---|---|---|---|---|---|
| 13 Oct 2026 | $1.64 | $-0.01 | -0.61% | 31,549 | $1.63 | $1.64 | $1.62 |
| 12 Oct 2026 | $1.65 | $-0.02 | -1.20% | 39,023 | $1.70 | $1.70 | $1.63 |
| 09 Oct 2026 | $1.67 | $0.01 | 0.60% | 18,746 | $1.61 | $1.67 | $1.60 |
| 08 Oct 2026 | $1.66 | $0.10 | 6.41% | 39,218 | $1.56 | $1.70 | $1.54 |
| 07 Oct 2026 | $1.56 | $-0.06 | -3.70% | 17,766 | $1.62 | $1.65 | $1.56 |
| 06 Oct 2026 | $1.62 | $0.00 | 0.00% | 30,044 | $1.60 | $1.66 | $1.60 |
| 05 Oct 2026 | $1.62 | $0.06 | 3.85% | 22,527 | $1.58 | $1.63 | $1.56 |
| 02 Oct 2026 | $1.56 | $-0.01 | -0.64% | 5,729 | $1.57 | $1.57 | $1.54 |
| 01 Oct 2026 | $1.57 | $-0.02 | -1.26% | 58,024 | $1.55 | $1.60 | $1.54 |
| 30 Sep 2026 | $1.59 | $-0.03 | -1.85% | 80,647 | $1.60 | $1.62 | $1.55 |
| 29 Sep 2026 | $1.62 | $-0.08 | -4.71% | 111,229 | $1.68 | $1.68 | $1.58 |
| 28 Sep 2026 | $1.70 | $-0.04 | -2.30% | 21,348 | $1.75 | $1.75 | $1.68 |
| 25 Sep 2026 | $1.74 | $0.01 | 0.58% | 9,266 | $1.72 | $1.74 | $1.72 |
| 24 Sep 2026 | $1.73 | $-0.01 | -0.57% | 3,971 | $1.70 | $1.73 | $1.68 |
| 23 Sep 2026 | $1.74 | $-0.02 | -1.14% | 41,035 | $1.80 | $1.80 | $1.71 |
| 22 Sep 2026 | $1.76 | $0.08 | 4.76% | 49,131 | $1.69 | $1.76 | $1.69 |
| 21 Sep 2026 | $1.68 | $-0.03 | -1.75% | 17,749 | $1.68 | $1.71 | $1.64 |
| 18 Sep 2026 | $1.71 | $0.06 | 3.65% | 14,974 | $1.65 | $1.71 | $1.65 |
| 17 Sep 2026 | $1.65 | $-0.09 | -5.19% | 7,346 | $1.67 | $1.67 | $1.65 |
| 16 Sep 2026 | $1.74 | $0.01 | 0.58% | 26,103 | $1.71 | $1.75 | $1.70 |
| 15 Sep 2026 | $1.73 | $0.04 | 2.37% | 28,134 | $1.69 | $1.73 | $1.65 |
Director Transactions Data provided by Morningstar.
| Date | Director | Type | Amount | Value | Notes |
|---|---|---|---|---|---|
| 22 Apr 2026 | Carmel Monaghan | Buy | 10,000 | $18,470 |
On-market trade.
|
| 31 Dec 2025 | Phillip Dubois | Expiry | 200,000 | $356,000 |
Options expired.
|
| 31 Dec 2025 | Anthony (Tony) Keane | Expiry | 200,000 | $356,000 |
Options expired.
|
| 31 Dec 2025 | John Keep | Expiry | 300,000 | $534,000 |
Options expired.
|
| 31 Dec 2025 | Scott Kirkland | Expiry | 500,000 | $890,000 |
Options expired.
|
| 18 Nov 2025 | Carmel Monaghan | Issued | 200,000 | $358,000 |
Issue of options.
|
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Dr Phillip James Dubois | Non-Executive Director | Sep 2020 |
Dr Dubois is neuroradiologist and nuclear imaging specialist. He was previously a Non-Executive Director of Magnetica Ltd (ASX: MNA) from 2003 to 2021 and an Executive Director of Sonic Healthcare Limited (ASX:SHL) from 2001 to 2020 he was CEO of Sonic's imaging division until 2023. He is also the founder and former CEO and Chairman of Queensland X Ray. He is currently an Associate Professor of Radiology at the University of Queensland Medical School. He has served on numerous government and radiology group bodies, including the councils of the Royal Australian and New Zealand College of Radiologists and the Australian Medical Association, and as Vice President of the Australian Diagnostic Imaging Association. He is Chair of Clinical Advisory Board.
|
| Mr Anthony (Tony) Keane | Non-Executive Director | Jun 2018 |
Mr Keane is an experienced business and finance executive and holds a number of independent non-executive director and advisory board roles. He also undertakes finance advisory and consultancy assignments for various business clients and previously held numerous roles with a major trading bank principally in business, corporate and institutional banking. He is currently an Independent Non-Executive Director and Chairman of National Storage Holdings Ltd, the holding company established for National Storage REIT, the first independent, internally managed and fully integrated owner and operator of self-storage centres listed on the ASX. He is chair of the risk committee.
|
| Mr John Keep | Non-Executive ChairmanNon-Executive Director | Mar 2018 |
Mr Keep has public company board and senior management experience in the healthcare and hospitality sectors including both medical diagnostic companies and start up enterprises. Previously Chief Executive of Queensland Diagnostic Imaging and later as Director of Operations at Lemarne Healthcare. He was previously Company Secretary of Castlemaine Tooheys Limited. He is member of the risk committee.
|
| Mr Scott Kirkland | Co-founderExecutive DirectorChief Executive OfficerManaging Director | Jul 2017 |
Mr Kirkland has held several senior sales and marketing positions, including Head of Client Sales at Quantcast, a US based AI technology company, prior to establishing EMVision as a leader in innovative neurodiagnostic technology. He is a member of the Australian Institute of Company Directors.
|
| Mr Patryk Kania | Non-Executive Director | Mar 2024 |
Mr Kania is a medical device executive with over 20 years of commercialisation and leadership experience in medical devices, pharma and health technologies working across the US, Europe and APAC, within sales and marketing management, and general management roles. Currently he is CEO and President USA of Field Orthopaedics Ltd. and has previously held senior roles at Smith Nephew, Abbott, J&J Medical and Roche. He is member of the risk committee.
|
| Ms Carmel Anne Monaghan | Non-Executive Director | Jun 2025 |
Ms Monaghan is healthcare leader and previously the Chief Executive Officer of Ramsay Health Care Australia (ASX:RHC). Prior to her appointment as CEO of Ramsay Australia, she was the Group Chief of Staff of Ramsays global operations, gaining experience and a comprehensive understanding of health care operations and strategy both in Australia and overseas. She also served as the Group Head of Marketing and Public Affairs, driving marketing, brand and communications strategy.
|
| Ms Emma Waldon | Company Secretary |
-
|
|
| Emma Waldon | Company Secretary |
-
|
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| Keysight Technologies Inc | 8,143,624 | 8.76% |
| Mr Scott Philip Kirkland | 3,861,987 | 4.15% |
| BNP Paribas Nominees Pty Ltd <Hub24 Custodial Serv Ltd> | 3,352,356 | 3.61% |
| Mr Ryan Michael Laws | 2,825,000 | 3.04% |
| Code Nominees Pty Ltd <Retail A/C> | 2,620,500 | 2.82% |
| J P Morgan Nominees Australia Pty Limited | 1,897,756 | 2.04% |
| Mr Vincent Michael O'Sullivan <The O'Sullivan A/C> | 1,800,600 | 1.94% |
| Mr Paul Raymond Brown & Mrs Angelique Susan Brown <Brown Family A/C> | 1,650,000 | 1.77% |
| JM Starcevich Investments Pty Ltd | 1,290,000 | 1.39% |
| Dr Ronald Peter Weinberger <Rpw A/C> | 1,288,262 | 1.39% |
| Uniquest Pty Limited | 1,200,000 | 1.29% |
| Busso Holdings Pty Ltd <Bew A/C> | 1,160,000 | 1.25% |
| BNP Paribas Nominees Pty Ltd <Ib Au Noms Retailclient> | 1,119,891 | 1.20% |
| Glensburg Pty Ltd <Tyto Corp Pension Fund A/C> | 1,112,000 | 1.20% |
| Dr Stuart Crozier | 1,061,894 | 1.14% |
| Walsh Prestige Pty Ltd <Walsh Family A/C> | 1,050,000 | 1.13% |
| Citicorp Nominees Pty Limited | 1,021,277 | 1.10% |
| Mr Martin Kolev | 1,011,985 | 1.09% |
| PIT2 Co Pty Ltd <Power Investment 2 A/C> | 959,469 | 1.03% |
| Bowling Family Holdings Pty Ltd <Bowling Fam Sf A/C> | 871,583 | 0.94% |